Lead Product(s) : Panobinostat lactate,Gadolinium
Therapeutic Area : Oncology
Study Phase : Phase I
Sponsor : Luca Szalontay
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : MTX110 (panobinostat) is a hydroxamic acid and acts as a non-selective histone deacetylase inhibitor (pan-HDAC inhibitor), which is investigated for the treatment of Treatment of Children with Newly Diagnosed Diffuse Midline Gliomas.
Product Name : MTX110
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
October 07, 2023
Lead Product(s) : Panobinostat lactate,Gadolinium
Therapeutic Area : Oncology
Highest Development Status : Phase I
Sponsor : Luca Szalontay
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
